Gastrin-releasing peptide
Gastrin-releasing peptide (GRP) is a neuropeptide that plays a crucial role in a variety of physiological and pathological processes. It is a 27-amino acid peptide that is primarily produced in the gastrointestinal tract and the central nervous system. GRP is known to stimulate the release of gastrin, a hormone that promotes the secretion of gastric acid in the stomach.
Function[edit | edit source]
Gastrin-releasing peptide functions as a neurotransmitter and a growth factor. It is involved in numerous physiological processes, including the regulation of gastric acid secretion, smooth muscle contraction, and cell proliferation. In the central nervous system, GRP acts as a neurotransmitter involved in pain transmission, thermoregulation, and circadian rhythms.
Structure[edit | edit source]
The structure of GRP is characterized by a 27-amino acid peptide chain. The peptide chain is synthesized as a larger precursor molecule, which is then cleaved to produce the active form of GRP. The active form of GRP is highly conserved across different species, indicating its important role in physiological processes.
Clinical significance[edit | edit source]
Abnormal levels of GRP have been associated with various diseases. Elevated levels of GRP have been found in certain types of cancer, including lung cancer, breast cancer, and prostate cancer. In these cancers, GRP acts as a growth factor, promoting the proliferation of cancer cells. In addition, GRP has been implicated in inflammatory bowel disease, where it is thought to contribute to inflammation and tissue damage.
Research[edit | edit source]
Research on GRP has focused on its role in disease and potential as a therapeutic target. Studies have investigated the use of GRP antagonists in the treatment of cancer and inflammatory diseases. In addition, research has explored the role of GRP in the central nervous system, with a focus on its potential involvement in neurological and psychiatric disorders.
See also[edit | edit source]
Resources[edit source]
Latest articles - Gastrin-releasing peptide
AI tools[edit source]
Generative AI tools and links to learn more on Gastrin-releasing peptide: ChatGPT - Bing Chat - Google Gemini. (caution advised).
Translate: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD